Research progress on immune response of B lymphocytes and anti-Mycobacterium tuberculosis infection

Open access


Multiple studies elucidated the importance of cellular immune mechanisms for protection against Mycobacterium tuberculosis. However, recent studies showed that B lymphocytes play a role that is underestimated through various interactions with cellular immune response, forming an important aspect of host defense against M. tuberculosis bacteria. Therefore, the author hereby proposes a progressive perspective for immunology of tuberculosis, i.e., cellular immunity and humoral immunity are not necessarily mutually exclusive. The present study summarizes recent studies that support the important role of B lymphocytes in terms of M. tuberculosis infection.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1 Maglione P Xu J Chan J et al. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. Immunol 2007 178(11):7222-34.

  • 2 Abebe F Holm-Hansen C Wiker HG et al. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Immunol 2007 66(23):176-91.

  • 3 Aiken AM Hill PC Fox A et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006 6:66-72.

  • 4 Tessema TA Bjune G Hamasur B et al. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis 2002 34(2):97-103.

  • 5 Dubaniewicz A Trzonkowski P Dubaniewicz-Wybieralska M et al. Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. Clin Immunol 2006 26(3):243-50.

  • 6 Maglione PJ Xu J Casadevall A et al. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. Immunol 2008 180(5):3329-38.

  • 7 Zhang M Zheng X Zhang J et al. CD19+CD1d+CD5+B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cell Immunol 2012 274(1-2):89-97.

  • 8 Corominas M Cardona L Gonzalez L et al. B-lymphocytes and costimulatory molecules in Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 2004 8(1):98-105.

  • 9 Zhang M Wang Z Graner MW et al. B cell infiltration is associated with the increased IL-17and IL-22expression in the lungs of patients with tuberculosis. Cell Immunol 2011 270(2): 217-23.

  • 10 MxManus DP Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008 21(1):225-42.

  • 11 Julian E Matas L Hernandez A et al. Evaluation of a new serodiagnostic tuberculosis test based on immunoglobulin A detection against Kp-90antigen. Int J Tuberc Lung Dis 2000 4(11):1082-5.

  • 12 Reis MC SILva BD Sousa EM et al. Role of antibodies reactive to HspX in discriminating pulmonary tuberculosis contacts with high risk of developing active disease. Braz J Infect Dis 2011 15(6):617-8.

  • 13 Reljic R Clark SO Williams A et al. Intranasal IFN-γ extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection. Clin Exp Immunol 2006 143:467-73.

  • 14 Saunders BM Britton WJ. Life and death in the granuloma : immunopathology of tuberculosis. Immunol Cell Biol 2007 85(2):103-11.

  • 15 Phuah JY MattILa J. Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol 2012 181(2):508-14.

  • 16 Jasmer PM Nahid P. Clinical practice. Latent tuberculosis infection. New Eng J Med 2002 347(23):1860-6.

  • 17 Encinales L Zuniga J Granados-Montiel J et al. Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mole Immunol 2010 47(5):1066-73.

  • 18 Balu S Reljic R Lewis MJ et al. A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol 2011 186(5):3113-9.

  • 19 Hoehlig K Lampropoulou V Roch T et al. Immune regulation by B cells and antibodies a view towrds the clinic. Adv Immunol 2008 98:1-38.

Gesamte Zeit Letztes Jahr Letzte 30 Tage
Abstract Views 0 0 0
Full Text Views 285 97 1
PDF Downloads 112 38 1